| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman
2 companies
Martin John C is a Director at GILEAD SCIENCES, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $364.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2018 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 50,000 | $83.56 | $4,177,824.31 | -0.8% | |
| Jan 2, 2018 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 50,000 | $73.62 | $3,681,235.38 | -0.5% | |
| Dec 1, 2017 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 73,333 | $74.98 | $5,498,385.00 | -0.8% | |
| Nov 1, 2017 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 73,333 | $75.13 | $5,509,697.47 | -1.2% | |
| Oct 2, 2017 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 73,333 | $82.56 | $6,054,319.49 | -1.2% | |
| Sep 1, 2017 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 73,333 | $83.11 | $6,094,991.81 | -1.2% | |
| Aug 1, 2017 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 73,333 | $75.86 | $5,562,777.38 | -2.3% | |
| Jul 3, 2017 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 73,333 | $71.00 | $5,206,892.33 | -2.3% | |
| Jun 1, 2017 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 73,333 | $65.24 | $4,784,530.92 | -2.2% | |
| May 1, 2017 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 73,333 | $68.31 | $5,009,428.56 | -2.3% |